Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

May 23, 2017

Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests

News

Patients taking Remicade (infliximab) can safely switch to treatment with biosimilar CT-P13, sold as Pfizer’s Inflectra and Celltrion Healthcare’s Remsima, according to recently published results of a clinical study. Results of the ... Read more

January 12, 2017January 12, 2017

Psoriasis May Be Associated with Liver Disease, Research Shows

News

People with psoriasis also may develop non-alcoholic fatty liver disease (NAFLD), a disorder that causes severe liver complications, researchers reported. The study, “Relationship Between Psoriasis And Non-Alcoholic Fatty Liver Disease,” ... Read more

January 3, 2017

Scientists Identify Molecules that Link Psoriasis and Heart Disease

News

Researchers have identified novel molecular pathways leading to inflammation in psoriasis that also can trigger heart failure in patients, according to results from two studies undertaken at Case Western Reserve ... Read more

December 20, 2016

Stelara May Block Protein That Fights Psoriasis, Study Says

News

Stelara (ustekinumab), an FDA-approved antibody treatment for psoriasis, may also inhibit a protein that fights the disease, according to new research. A University of Zurich team led by Burkhard Becher conducted ... Read more

November 10, 2016

Phototherapy Appears to Improve Psoriasis, Study Shows

News

Narrowband UVB light therapy (phototherapy) can improve psoriasis in patients by decreasing the levels of a protein called MMP-2, which contributes to the pathology of this disease, according to a ... Read more

November 3, 2016November 3, 2016

Troubled Genetic Pathways Linked to Psoriasis Seen to Respond to Humira Treatment

News

Researchers identified abnormal genetic pathways associated with psoriasis, some of which may be restored after treatment with Humira (adalimumab), according to a new study published in the journal BMC Genomics. In the ... Read more

September 20, 2016

Treating Psoriatic Dactylitis with TNF-Alpha Inhibitors Like Remicade Improves Symptoms, Report Shows

News

New research suggests that symptoms of psoriatic dactylitis, a manifestation of psoriatic arthritis (PsA), can be improved with therapies that promote the inhibition of TNF-alpha, one of the most important molecular players ... Read more

August 10, 2016August 10, 2016

Potential Oral Treatment for Psoriasis Shows Efficacy in Phase 2/3 Study

News

Can-Fite BioPharma has announced the completion of its Phase 2/3 clinical trial evaluating Piclidenoson (CF101) as an oral treatment for moderate to severe psoriasis. The results show that Piclidenoson is both ... Read more